Jam

Kewaunee Scientific (KEQU) reported strong Q1 fiscal year 2026 results. Sales increased 46.9% to $71.104 million, with pre-tax earnings up 61.3% to $3.920 million. Diluted EPS reached $1.04. The domestic segment saw a 53% sales increase, boosted by the Nu Aire acquisition. International sales rose 30.2%, reflecting improved project delivery. The company is investing in corporate infrastructure to support future growth, anticipating uneven performance for the rest of the year but expects better unadjusted EBITDA than fiscal year 2025. Backlog stood at $205 million.

Verizon will launch the iPhone 17 lineup, including the iPhone Air, on September 19, 2025, with pre-orders starting September 12. Customers can get up to $1,100 off with trade-in and eligible unlimited plans. The lineup features four models with enhancements like Center Stage front camera and Ceramic Shield 2. Verizon’s plans start at $30 per line for four lines, offering a three-year price guarantee. Bundled offers include Apple Watch Series 11, iPads, and deals for business customers.

Aviat Networks (NASDAQ: AVNW) will release its fiscal 2025 fourth quarter financial results on September 10, 2025, after market close, for the period ending June 27, 2025. A conference call and webcast will follow at 4:15 p.m. ET, featuring CEO Pete Smith and CFOs to discuss the results. The webcast will be accessible via the Investor Relations section of Aviat Networks’ website, where a replay will also be available. Aviat Networks is a provider of wireless transport and access solutions, serving various sectors worldwide.

Veeva Systems announced that Gilead Sciences has adopted Veeva Vault CRM, deepening their partnership. Veeva’s next-gen CRM integrates agentic AI for pre-call planning, automated compliant communication, and voice control. Gilead expects AI to optimize sales, improve engagement, and accelerate medicine delivery. Veeva is focusing on AI-powered solutions, giving it a competitive edge in the life sciences CRM market by addressing regulatory and compliance challenges. Veeva serves over 1,500 life science customers worldwide, from pharmaceutical to biotech companies.

Wyndham Rewards partners with KrisFlyer, enabling members to convert points to KrisFlyer miles. Members can earn KrisFlyer miles on stays or convert Wyndham Rewards points, starting at 6,000 points for 1,200 miles. This partnership enhances the value of Wyndham Rewards for its 120 million members, offering access to flights and upgrades on Singapore Airlines and its network. The collaboration reflects the trend of enhancing customer loyalty through strategic airline partnerships.

Morningstar and PitchBook have launched the Morningstar PitchBook US Modern Market 100 Index, blending public and private market performance. The index comprises 90 publicly listed companies and 10 late-stage, venture-backed firms, reflecting the evolving capital markets where companies stay private longer. Utilizing transparent pricing from public exchanges and secondary private market transactions, the index offers investors a unified benchmark to assess both public and private market leaders. It aims to enhance diversification and unlock growth potential by incorporating innovative private companies like SpaceX and OpenAI.

Commvault (CVLT) sponsors Agustín Tapia, a top-ranked padel player, aligning with the sport’s global growth and its themes of agility and resilience. Tapia, known for strategic prowess, mirrors Commvault’s focus on data protection and rapid recovery from cyber threats. The partnership aims to boost Commvault’s brand awareness and emphasize the importance of cyber resilience, particularly in light of padel’s surging popularity with over 30 million players worldwide. This highlights the increasing convergence of sports marketing with technology solutions.

Barton Gold Holdings (BGDFF) is participating in the Beaver Creek Precious Metals Summit. Presentation materials are available on the ASX website and Barton’s investor relations page. Barton, strategically located in South Australia’s Gawler Craton, aims for 150,000ozpa gold production, leveraging its brownfield mines and sole regional gold mill. The company’s JORC Mineral Resources total 2.2Moz Au and 3.1Moz Ag. Projects include Challenger, Tarcoola, Tunkillia, and Wudinna, with Tarcoola featuring high-grade discoveries. Investors can contact Alexander Scanlon or Jade Cook for inquiries.

Lobe Sciences will participate in the Clusterbusters 20th Annual U.S. Patient Conference (Sept 11-14, 2025) to present research on L-130, Conjugated Psilocin™, a potential treatment for chronic cluster headaches. The company recently secured $6 million in funding, with a potential $20 million more, to complete FDA submission for L-130. Lobe aims to connect with patients, form an advocacy team, and gather input for clinical trial design, leveraging patient experiences provided by Clusterbusters, a supporting advocacy group.

Rapport Therapeutics (RAPP) announced the pricing of its public offering of 9,615,385 shares at $26.00 per share, potentially generating $250 million in gross proceeds. Underwriters have a 30-day option to purchase an additional 1,442,307 shares. The offering, managed by Goldman Sachs, Jefferies, TD Cowen, and Stifel, is expected to close around September 11, 2025. Funds will support the clinical-stage biotech’s work on neurological and psychiatric disorders.